Title |
Personalized vaccine for patients with AML
|
Institution |
BETH ISRAEL DEACONESS MEDICAL CENTER, BOSTON, MA
|
Principal Investigator |
AVIGAN, DAVID
|
NCI Program Director |
Merritt
|
Cancer Activity |
Clinical Oncology
|
Division |
DCTD
|
Funded Amount |
$739,429
|
Project Dates |
12/09/2016 - 11/30/2021
|
Fiscal Year |
2017
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer (100.0%)
|
Leukemia (100.0%)
|
Research Type |
Systemic Therapies - Clinical Applications
|
Abstract |
No abstract available. |